Trial intelligence / Profile preview

Gemcitabine vs Gemcitabine + Cisplatin as adjuvant chemotherapy after curative resection of cholangiocarcinoma

TCTR20161101003Phase 3Unknown

Sponsor
Faculty of Medicine, Khon Kaen University
Start
Nov 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of gemcitabine, cisplatin in cholangiocarcinoma (CCA), sponsored by Faculty of Medicine, Khon Kaen University. Status: unknown.

02

Drugs

gemcitabinecisplatin
03

Conditions

cholangiocarcinoma (CCA)

Beyond the preview

Go deeper on TCTR20161101003.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20161101003.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call